Hims & Hers Health Inc. (HIMS) saw its stock price plummet 5.03% during intraday trading on Wednesday, extending losses from the previous session.
The sharp decline follows the telehealth company's report of a first-quarter loss and the issuance of weak earnings guidance for the year ahead, which triggered significant selling pressure.
Despite the negative price action, options trading activity for HIMS remained elevated, with call options accounting for 71% of the total volume on Tuesday, indicating some traders may be positioning for a potential rebound.